Related content

Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia

By Genazzani Alessandro   Lanzoni Chiara   Ricchieri Federica   Baraldi Enrica   Casarosa Elena   Jasonni Valerio  

Gynecological Endocrinology, Vol. 23, Iss. 3, 2007-03 ,pp. : 146-152

Informa Healthcare

Access to resources Recommend Favorite

Growth hormone secretion is impaired but not related to insulin sensitivity in non‐obese patients with polycystic ovary syndrome

By de Boer Jacoba A.M.  

Human Reproduction, Vol. 19, Iss. 3, 2004-03 ,pp. : 504-509

Oxford University Press

Access to resources Recommend Favorite

Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome

By Yilmaz Murat   Bi˙ri˙ Aydan   Bukan Neslihan   Karakoç Ayhan   Sancak Banu   Törüner Füsun   Paşaoğlu Hatice  

Gynecological Endocrinology, Vol. 20, Iss. 5, 2005-05 ,pp. : 258-263

Informa Healthcare

Access to resources Recommend Favorite

Metformin versus flutamide in the treatment of metabolic consequences of non-obese young women with polycystic ovary syndrome: a randomized prospective study

By Sahin I   Serter R   Karakurt F   Demirbas B   Culha C   Taskapan C   Kosar F   Aral Y  

Gynecological Endocrinology, Vol. 19, Iss. 3, 2004-09 ,pp. : 115-124

Informa Healthcare

Access to resources Recommend Favorite

Low‐dose combination of flutamide, metformin and an oral contraceptive for non‐obese, young women with polycystic ovary syndrome

By Ibáñez Lourdes  

Human Reproduction, Vol. 18, Iss. 1, 2003-01 ,pp. : 57-60

Oxford University Press

Access to resources Recommend Favorite